<DOC>
	<DOCNO>NCT00678652</DOCNO>
	<brief_summary>The purpose study determine whether vaccine base outer membrane vesicle ( NOMV ) genetically detoxify group B meningococcus safe effective use vaccine . If , NOMV vaccine combine NOMV two genetically modify strain potentially globally effective vaccine group B meningococcus .</brief_summary>
	<brief_title>Group B Meningococcal Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy ( physical examination medical history ) military civilian male female ; Age 1845 year ; Able give inform consent , understand risk benefit study , assent use blood sample future research ; understand willing comply protocol procedure time commitment ; Females must negative urine pregnancy test vaccination day dose AND agree practice effective birth control method necessary , 6 month first vaccination ; Military servicemembers wish participate must obtain write permission immediate supervisor , department chief equivalent , company commander equivalent . Current history significant organ/system disease ; History allergy vaccine ; History allergy aluminum hydroxide ; Presence significant unexplained laboratory abnormality opinion PI may potentially confound analysis study result ; HIV seropositive immunosuppressive state ; Positive test HBsAg hepatitis C antibody ; Evidence admission ongoing drug alcohol abuse/dependence ; Intention leave area study volunteer would miss 1 study day ; Prior receipt group B meningococcal outer membrane protein ( OMP ) vaccine vaccine contain meningococcal OMP ; Has receive plan receive live vaccine , Investigational New Drug ( IND ) product significant immunosuppressive therapy* 28 day prior , inactivated vaccine within 14 day initial vaccination throughout study , receive parenteral immunoglobulin blood product within 3 month study initiation ; ( Intraarticular , topical , intranasal steroid , steroid apply eye , â‰¤ 7 day oral steroid general acceptable , depend formulation condition prescribe . Inclusion individual receive medication make PI case case basis ) High level baseline bactericidal antibody vaccine strain screening ( &gt; 1:16 ) and/or throat carriage Neisseria meningitidis time screen ; Positive urine pregnancy test prior vaccination ; Lactation first dose 3 month last dose ; Any condition opinion investigator might interfere study vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Meningococcal vaccine</keyword>
	<keyword>Neisseria meningitidis</keyword>
</DOC>